Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.


  • Gardiner Harris science reporter for "The New York Times"
  • Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of

Topics + Tags


comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 09 2015Russia denies the U.S. claim that cruise missiles aimed at Syria hit Iran. Doctors Without Borders demands an independent inquiry on the Afghanistan hospital bombing. And a group of four Tunisian organizations wins the Nobel Peace Prize. A panel of journalists joins guest host Indira Lakshmanan for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 09 2015The House leadership postpones its speaker vote after Rep. Kevin McCarthy (R-Calif.) drops out. Hillary Clinton announces her opposition to the new Pacific trade agreement. And the head of Volkswagen U.S. testifies before Congress on the emissions scandal. Guest host Indira Lakshmanan and a panel of journalists discuss the week’s top national stories.